beta-lactams has been researched along with sparfloxacin in 2 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (sparfloxacin) | Trials (sparfloxacin) | Recent Studies (post-2010) (sparfloxacin) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 694 | 69 | 79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Espasa, M; Gómez-Martínez, J; Jiménez de Anta, MT; Marco, F; Martínez, JA; Mensa, J | 1 |
| Harigae, H; Ishikawa, S; Kaku, M; Kanemitsu, K; Kunishima, H; Saga, T; Takemura, H | 1 |
2 other study(ies) available for beta-lactams and sparfloxacin
| Article | Year |
|---|---|
[In vitro activity of fluoroquinolones and oral beta lactam antibiotics against clinical isolates of Escherichia coli].
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests | 1999 |
Efficacy of amikacin combinations for nocardiosis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ciprofloxacin; DNA, Ribosomal; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Streptomyces; Sulfamethoxazole; Trimethoprim | 2003 |